v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
May 31, 2025
May 31, 2024
Aug. 31, 2024
Aug. 31, 2023
Cash flows from operating activities        
Net loss $ (7,100,730) $ (3,929,520) $ (26,315,396) $ (6,317,373)
Adjustments for non-cash income and expenses:        
Depreciation of property, plant and equipment 84,729 187,729 251,878 132,170
Amortization of technology-related intangible assets 2,707,257 3,118,041 4,157,388 4,157,389
Stock based expense 3,261,676    
Technology-related intangible asset impairment     20,580,040
Property, plant and equipment impairment and abandonments     21,387
Changes in operating assets and liabilities:        
(Increase)/decrease in accounts receivables 3,419 (12,647) (18,784) 41,830
Decrease/(increase) in inventories 25,026 (104,992) 170,431 (11,482)
Decrease in deposit, prepayments and advances to suppliers 32,624 147,654 502,701 214,159
Decrease in operating lease right-of-use assets 61,007 61,351 71,374 170,999
Increase/(decrease) in accounts payable and accruals 14,162 56,584 97,012 (45,942)
Decrease in deferred revenue 6,002 (48,632) (430,057) (73,003)
Decrease in operating lease liabilities (63,847) (64,369) (74,706) (189,830)
Increase/(decrease) in other payables 68,580 (6,258) 68,344 (4,493)
Increase in amounts due to shareholders     970,597 229,794
Net cash generated from /(used in) operations (900,095) (595,059) 30,822 (1,674,395)
Cash flows from investing activity        
Purchase of property, plant and equipment (5,902) (102,414) (146,269) (14,189)
Cash used in investing activity (5,902) (102,414) (146,269) (14,189)
Cash flows from financing activities        
Loan from shareholders 972,045 524,587    
Payments of hire purchase (6,003) (5,885) (6,677) (8,587)
Payment of offering costs (42,454) (449,576) (449,576)
Proceeds from issuance of common stock     1,143,728
Proceeds from shares to be issued     991,052
Proceeds from capital contribution 65,598 266,517
Net cash (used in)/generated from financing activities 923,588 134,724 (456,253) 2,392,710
Net (decrease)/increase in cash and cash equivalents 17,591 (562,749) (571,700) 704,126
Effect of exchange rate changes (89,560) (170,798) (54,364) (77,381)
Cash and cash equivalents at start of year 152,985 779,049 779,049 152,304
Cash and cash equivalents at end of year 81,016 45,502 $ 152,985 $ 779,049
Supplemental disclosure of non-cash investing and financing information :        
Common stock issued for consulting service in related to Initial public offering $ 2,718,064